Torren Management’s Orthofix Medical OFIX Stock Holding History

Torren Management’s Portfolio OFIX Stock Details OFIX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-24	Closed	-$364	–	1297
2025 Q4	$364	Buy	+24	New	+$366	﹤0.01%	1374

Other funds holding OFIX

ECM

Engine Capital Management New York $828M AUM 6.49% 1-Year Est. Return

JIC

Juniper Investment Company New York $313M AUM 79.58% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

PCMI

Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Torren Management's OFIX Position: Q1 2026 in Review

Torren Management sold out of Orthofix Medical (OFIX) in Q1 2026, closing a stake of 24 shares — an estimated $364 sold.

Torren Management first reported a position in OFIX in Q4 2025 and held it in 1 quarter. The position peaked at $364 in Q4 2025. 147 funds tracked by Wall St. Rank hold OFIX as of Q1 2026.

Torren Management reported no remaining Orthofix Medical position as of Q1 2026 after selling out during the quarter.
Torren Management sold 24 Orthofix Medical shares in Q1 2026, an estimated $364.
Torren Management first reported a position in Orthofix Medical in Q4 2025 and held it in 1 quarter.
Torren Management's Orthofix Medical position peaked at $364 in Q4 2025.
147 funds tracked by Wall St. Rank held Orthofix Medical as of Q1 2026.

Based on Torren Management's 13F filing for Q1 2026, filed 30 Apr 2026.